Recombinant Human IGFBP-4 Protein_90476ES(90476ES)
产品应用
Insulin-like Growth Factor Binding Protein-4 (IGFBP-4) is the smallest member of the IGFBP family, with a molecular weight of approximately 24 kDa, encoded by the IGFBP4 gene located on human chromosome 17q12-21.1. The protein consists of 237 amino acids and contains the conserved N-terminal, C-terminal, and variable L-domains characteristic of the IGFBP family, including two additional interconnected cysteine residues in the L-domain. IGFBP-4 binds both IGF-I and IGF-II with high affinity, exhibiting 2–10 fold higher affinity for IGF-II than for IGF-I. This binding prolongs IGF half-life and inhibits ligand-receptor interactions, thereby attenuating IGF-mediated proliferation and differentiation in most physiological contexts.

SDS-PAGE
R: reducing condition, N: non-reducing condition

RP-HPLC
>95% as determined by RP-HPLC.

Bioactivity
Measured by its ability to inhibit the biological activity of IGFII on MCF7 human breast adenocarcinoma cells. The expected IC50 for this effect is typically 31-48ng/mL in the presence of 14 ng/mL human IGFII.
高活性、高纯度、低内毒素、高稳定性
-25 ~ -15℃保存,收到货之日起有效期1年。复溶后,在4°C下可稳定保存1周。复溶后,-20℃~ -80℃下可稳定保存3-6个月。建议分装后于-20℃或-80℃冷冻保存以延长保质期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
421
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
421
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
550
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
385
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
2527
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
2411
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1468
2026-04-22
【应用方向】TNFR蛋白家族概述
1452
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1669
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
1204
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
1270
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
1377
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
1120
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14980
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11596
2026-09-21
南美超级胎牛血清999尝鲜特惠





